P16533 AF NFT

Leukotoxin-activating lysine-acyltransferase LktC serotype A1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibmd6okklgilyvxvgx636dtjxiurzoduoooet336lmbhwa7p3ldbu/metadata.json
IPFS of structure file: 
bafybeic2rz6tza72vmfuvqd4gaupzdom2wd4dsxjhcisvyne5eiwsf43ji/AF-P16533-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xcE49072BbEac0d780Ad4458e0754bC2C578fFE78
First NFT owner address (bech32): 
genesis1eeysw2a74sxhszk5gk8qw49u93tcllnc5uday5
Current NFT ID #215500 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
215500
Accession (UniProt):
P16533
Name::
Leukotoxin-activating lysine-acyltransferase LktC serotype A1
Experimental Method:
Predicted structure
Sequence source:
MANNHEIMIA HAEMOLYTICA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P16533 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P16533|LKTC1_MANHA Leukotoxin-activating lysine-acyltransferase LktC serotype A1 OS=Mannheimia haemolytica OX=75985 GN=lktC PE=3 SV=1 MNQSYFNLLGNITWLWMNSSLHKEWSCELLARNVIPAIENEQYMLLIDNGIPIAYCSWADLNLETEVKYIKDINSLTPEEWQSGDRRWIIDWVAPFGHSQLLYKKMCQKYPDMIVRSIRFYPKQKELGKIAYFKGGKLDKKTAKKRFDTYQEELATALKNEFNFIKK